Synthesis of P-triazinylphosphonium salts - hybrid molecules with potential antimicrobial activity

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 3, 2011, Pages 387-391

  Kolesińska, Beata ^a   Motylski, Rafał ^a   Kamiński, Zbigniew J ^a   Kwinkowski, Marek ^b   Kaca, Wiesław ^b  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

1,3,5 triazine; Hybrid drugs; Phosphonium biocide; Phosphonium salt

Indexed keywords

2 CHLORO 4,6 DIBENZYLOXY 1,3,5 TRIAZINE; 2 CHLORO 4,6 DIMETHOXY 1,3,5 TRIAZINE; ANTIBIOTIC AGENT; PHOSPHONIUM DERIVATIVE; TRIAZINE DERIVATIVE; TRIPHENYLPHOSPHINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; CHEMICAL REACTION; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMAL BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS MIRABILIS; SEROTYPE; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROPATHOGENIC ESCHERICHIA COLI; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; ORGANOPHOSPHORUS COMPOUNDS; PROTEUS MIRABILIS; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES;

EID: 79956331493     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hulsman N., Medema J.P., Bos C., Jongejan A., Leurs R., Smit M.J., de Esch I.J.P., et al.: J. Med. Chem. 50, 2424 (2007).
2. (a) Kaswala P.B., Chikhalia K.H., Shah N.K., Patel D.P., Patel D.H., Mudaliar G.V.: ARKIVOC XI, 326 (2009);
3. (b) Garmouna M., Blanchoud H., Teil M., Blanchard M., Chevreuil M.: Water Air Soil Pollut. 132, 1 (2001).
4. Jain S., Bhambi D., Sharma, R., Talesara L.: Ind. J. Pharm. Sci. 69, 28 (2007).
5. (a) Klenke B., Stewart M., Barett M.P., Brun R., Gilbert I.H.: J. Med. Chem. 44, 3440 (2001);
6. (b) Patel R.B., Chikhalia K.H., De Clercq E.: J. Braz. Chem. Soc. 18, 2 (2007).
7. (a) Srinivas K., Shrinivas U., Rao V.J., Bhanuprakash K., Chishore K.H., Murty U.S.N.: Bioorg. Med. Chem. Lett. 15, 1121. (2005);
8. (b) Lubbers T., Angechm P., Gumunder H., Herzig S., Kulhanek J.: Bioorg. Chem. Lett. 3, 821 (2000);
9. (c) Desai A.D., Mahajan D.H., Chikhalia K.H.: Ind. J. Chem. 46B, 1169 (2007);
10. (d) Srinivas K., Srinivas U., Bhanuprakash K., Harakishore K., Murthy U.S.N., Rao V.J.: Eur. J. Med. Chem. 41, 1240 (2006).
11. (a) Alteramn M., Samulsson B.: J. Med. Chem. 41, 3782 (1998);
12. (b) Katritzky A.R., Rogovoy b.V., Vvedensky V.Y., Hebert N., Forood B.: J. Org. Chem. 66, 6797 (2001);
13. (c) Mayumi O., Kawahara N.; Santo Y.: Cancer Res. 56, 1512 (1996).
14. (a) Brozowski Z., Gdaniec M.: Eur. J. Med. Chem. 35, 1053 (2000);
15. (b) Shinichi Y., Yasuhisa F., Ichiro K., Hisashi Y., Toshiyuki M., et al.: J. Natl. Cancer Inst. 98, 545 (2006).
16. Youngyuth Y., Tirayut V., Netnapa, C., Sumalee K., Gordon L.: J. Med. Chem. 43, 2738 (2000).
17. Petrocci A.N.: in Disinfection, Sterilization and Preservation.; Block S.S., Ed., p. 309, Lea & Febiger, Philadelphia 1983.
18. (a) Thorsteinsson T., Loftsson T., Masson M.: Curr. Med.Chem. 10, 1129 (2003);
19. (b) Thorsteinsson T., Masson M., Kristinsson K.G., Hjá lmarsdóttir M.A., Hilmarsson H., Loftsson T.: J. Med. Chem. 46, 4173 (2003).
20. Bodor N., Kaminski J.J., Selk S.: J. Med. Chem. 23, 469 (1980).
21. Kanazawa A., Ikeda T., Endo T.: Antimicrob. Agents Chemother. 38, 945 (1994).
22. Kelly L., M., Jacobs M.R., Appelbaum P.C.: J. Antimicrob. Chemother. 43, 707 (1999).
23. Jian H., Anderson M.H., Shi W., Eckert R.: Int. J. Antimicrob. Agents 33, 532 (2009).
24. Kamiński Z.J.: Synthesis 10, 917 (1987).